DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Liver Transplantation - Pipeline Review, H1 2016" report to their offering.
This report provides comprehensive information on the therapeutic development for Liver Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Transplantation and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Liver Transplantation Overview
- Therapeutics Development
- Pipeline Products for Liver Transplantation - Overview
- Pipeline Products for Liver Transplantation - Comparative Analysis
- Liver Transplantation - Therapeutics under Development by Companies
- Liver Transplantation - Therapeutics under Investigation by Universities/Institutes
- Liver Transplantation Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Liver Transplantation - Products under Development by Companies
- Liver Transplantation - Products under Investigation by Universities/Institutes
- Liver Transplantation - Companies Involved in Therapeutics Development
- Astellas Pharma Inc.
- Conatus Pharmaceuticals Inc.
- Digna Biotech, S.L.
- Dompe Farmaceutici S.p.A.
- Novartis AG
- RedHill Biopharma Ltd.
For more information visit http://www.researchandmarkets.com/research/d3lk8c/liver
